Zidovudine glucuronidation in human liver: Interindividual variability

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 8, 1996, Pages 329-334

  Pacifici, G M ^a   Evangelisti, L ^a   Giuliani, L ^a   Metelli, R M ^a   Giordani, R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antivirals; Glucuronosyl transferase; Liver; Variability; Zidovudine

Indexed keywords

BILIRUBIN; GLUCURONIC ACID; GLUCURONOSYLTRANSFERASE; ZIDOVUDINE; ZIDOVUDINE GLUCURONIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME KINETICS; FEMALE; GLUCURONIDATION; HUMAN; HUMAN TISSUE; LIVER METABOLISM; LIVER MICROSOME; MAJOR CLINICAL STUDY; MALE; MICHAELIS MENTEN KINETICS; RADIOACTIVITY; RADIOMETRY; VIRUS REPLICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BILIRUBIN; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; LIVER; MALE; MICROSOMES; MIDDLE AGED; RADIOMETRY; ZIDOVUDINE;

EID: 0029782873     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Blum MR, Liao SHT, Good SS, De Miranda P 1988 Pharmacokinetic and bioavailability of zidovudine in humans. Am J Med 85 (Suppl 2A): 189-194
2. Bock KW, Scherenk D, Foster A, Griese E-U, Morike K, Brockmeier D, Eichelbaum M 1994 The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferase in man using sparteine, caffeine and paracetamol as probes. Pharmacogenetics 4: 209-218
3. Bock KW, Brunner G, Hoensch H, Huber E, Jostin D 1978 Determination of microsomal UDP-glucuronosyltransferase in needle-biopsy specimens of human liver. Eur J Clin Pharmacol 14: 367-373
4. Bock KW, Burchell B, Dutton GJ, Hanninen O, Mulder GJ, Owens IS, Siest G, Tephly TR 1983 UDP-glucuronosyl transferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol 32: 953-955
5. Burchell B, Coughtrie MWH 1989 UDP-glucuronosyl-transferases. Pharm Ther 43: 261-289
6. Burger DM, Meenhorst PL, ten Napel C HH, Mulder JW, Neef C, Koks CHW, Bult A, Beijnen JH 1994 Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions. AIDS 8: 1683-1689
7. Cappiello M, Giuliani L, Pacifici GM 1991 Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5′-diphosphoglucuronic acid in human tissues. Eur J Clin Pharmacol 41: 345-350
8. Cload PA 1989 A review of the pharmacokinetics of zidovudine in man. J Infection 18 (Suppl 1): 15-21
9. Cretton EM, Sommadossi J-P 1991 Modulation of 3′-azido-3′-deoxythymidine catabolism by probenecid and acetaminofen in freshly isolated rat hepatocytes. Biochem Pharmacol 42: 1475-1480
10. Cretton EM, Waterhous DV, Bevan R, Somadossi JP 1990 Glucuronidation of 3′-azido-3′-deoxythymidine by rat and human liver microsomes. Drug Metab Dispos 18: 369-372
11. De Miranda P, Good SS, Yarchoan R, Thomas RV, Blum MR, Myers CE, Broder S 1989 Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin Pharmacol Ther 46: 494-500
12. Gallicano K, Sahai J, Ormsby E, Cameron DW, Pakuts A, McGilveray I 1993 Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients. Br J Clin Pharmacol 36: 128-131
13. Gitterman SR, Drusano GL, Egorin MJ, Standiford HC 1990 Population pharmakokinetics of zidovudine. Clin Pharmacol Ther 48: 161-167
14. Good SS Koble, CS, Crouch R, Johnson RL, Rideout JL, De Miranda P 1990 Isolation and characterization of an ether glucuronide of zidovudine in monkeys and humans. Drug Metab Dispos 18: 321-326
15. Haumont M, Magdalou J, Lafaurie C, Ziegler J-M, Siest G, Colin J-N 1990 Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3′-azido-3′-deoxythymidine: Characterization of the enzyme in human and rat liver microsomes. Arch Biochem Biophys 281: 264-270
16. Howe JL, Back DJ, Colbert J 1992 Extrahepatic metabolism of zidovudine. Br J Clin Pharmacol 33: 190-192
17. Kornhauser DM, Hendrix CW, Nerhood LJ, Petty BG, Woods AS, Bartlett JG, Lietman PS 1989 Probenecid and zidovudine metabolism. Lancet ii: 473-475
18. Liu HF, Vincent-Viry M, Galteau MM, Gueguen R, Magdalou J, Nicolas A, Leroy P, Siest G 1991 Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic? Eur J Clin Pharmacol 41: 153-159
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275
20. Macleod R, Eagling VA, Sim SM, Back DJ 1992 In vitro inhibition studies of the glucuronidation of 3′-azido-3′-deoxythymidine catalysed by human liver UDP-glucuronosyl transferase. Biochem Pharmacol 43: 382-386
21. Nicolas F, De Sousa G, Thomas P, Placidi M, Lorenzon G, Rahmani R 1995 Comparative metabolism of 3′-azido-3′-deoxythymidine in culturated hepatocytes from rats, dog, monkey and humans. Drug Metab Dis 23: 308-313
22. O'Hanley PD, Tam JY, Holodniy M 1992 Infectious disorders. In: Melmon KL, Morelli HF, Hoffman BB, Nierenberg DW (eds) Clinical Pharmacology. 3rd edn., McGraw-Hill, New York, p 687
23. Pacifici GM, Franchi M, Giuliani L, Rane A 1990a Development of the glucuronosyltransferase and sulphotransferase towards 2-naphthol in human fetus. Dev Pharmacol Ther 14: 108-114
24. Pacifici GM, Viani A, Franchi M, Santerini S, Temellini A, Giuliani L, Carrai M 1990b Conjugation pathways in liver disease. Br J Clin Pharmacol 30: 427-435
25. Rajaonarison JF, Lacarelle B, De Sousa G, Catalin J, Rahmani R 1991 In vitro glucuronidation of 3′-azido-3′-deoxythymidine by human liver. Drug Metab Dispos 19: 809-815
26. Resetar A, Minick D, Spector T 1991 Glucuronidation of 3′-azido-3′-deoxythymidine catalysed by human liver UDP-glucuronosyltransferase. Biochem Pharmacol 42: 559-568
27. Resetar A, Spector T 1989 Glucuronidation of 3′-azido-3′-deoxythymidine: human and rat enzyme specificity. Biochem Pharmacol 38: 1389-1393
28. Sale M, Sheiner LB, Volberding P, Blaschke TF 1993 Zidovudine response relationships in early human immunodeficiency virus infection. Clin Pharmacol Ther 54: 556-566
29. Sim SM, Back DJ, Brekenridge AM 1991 The effect of various drugs on the glucuronidation of zidovudine azidothymidine; AZT by human liver microsomes. Br J Clin Pharmacol 32: 17-21
30. Temellini A, Giuliani L, Pacifici GM 1991 Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver. Br J Clin Pharmacol 31: 661-664
31. Tephly TR, Townsend M, Green M 1989 UDP-glucuronosyltransferases in the metabolic disposition of xenobiotics. Drug Metab Dispos 20: 689-695
32. Van Roy P, Heirwegh KPM 1968 Topology and regulation in sealed native microsomes from rat liver. Arch Biochem Biophys 263: 216-225
33. Vincent-Viry W, Cossy C, Galteau MM, Gueguen R, Magdalou J, Nicolas A, Leroy P, Siest G 1995 Lack of a genetic polymorphism in the glucuronidation of fenofibric acid. Pharmacogenetics 5: 50-52
34. Winsten S, Cehelyk B 1969 A rapid microdiazo technique for measuring total bilirubin. Clin Chim Acta 25: 441-446
35. Yarchoan R, Mitsuya H, Myers CE, Broder S 1989 Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine zidovudine and related dideoxynucleosides. N Engl J Med 321: 726-738
36. Yue QY, Svensson J-O, Alam C, Sjoqvist F, Sawe J 1989 Interindividual and interethnic differences in the demethylation and glucuronidation of codeine. Br J Clin Pharmacol 28: 629-637